Shares Investor Evening (Edinburgh)
Thursday 12 September 2019
Come and join Shares and AJ Bell Media at their Edinburgh Investor Evening on Thursday 12 September 2019 at the Radisson Blu Hotel, located in the heart of the historic Royal Mile.
Our Edinburgh evening event provides an opportunity for Board Directors, from dynamic companies that are listed on the London Stock Exchange, to make presentations and talk about their company's business plans to existing & potential new investors.
During the event and afterwards over drinks and food, attendees will have the chance to get to know the companies better by talking one on one with the company directors.
Belvoir Group (BLV) is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents
Diurnal (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Open Orphan (ORPH) a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe.
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Registration and coffee
Dorian Gonsalves, CEO - Belvoir Group (BLV)
Martin Whitaker, CEO - Diurnal (DNL)
Cathal Friel, CEO - Open Orphan (ORPH)
Drinks reception and canapés
Radisson Blu Hotel Edinburgh